Do Sex-Specific Factors Influence the Surgical Treatment of Facial Skin Cancer?
incidence
public health
sex ratio
skin neoplasms
surgery
Journal
Journal of personalized medicine
ISSN: 2075-4426
Titre abrégé: J Pers Med
Pays: Switzerland
ID NLM: 101602269
Informations de publication
Date de publication:
27 Jul 2023
27 Jul 2023
Historique:
received:
01
07
2023
revised:
20
07
2023
accepted:
26
07
2023
medline:
25
8
2023
pubmed:
25
8
2023
entrez:
25
8
2023
Statut:
epublish
Résumé
Facial skin cancer (FSC) is prone to incomplete excision due to the sophisticated anatomy and the aesthetic importance of the face. In this study, we sought to investigate to what extent sex-specific differences and other operation-, patient-, and cancer-specific factors influence the re-resection rate in FSC surgery, in order to provide personalized treatment strategies to patients. In this retrospective study, patients (>18 years) undergoing surgical excision of an FSC were enrolled. Each patient's demographic data, cancer location, the surgical team, primary and secondary surgeries were analyzed. Overall, 469 patients (819 surgeries) were included. The mean age was 69 ± 15 years. No significant association between sex-specific factors (surgeon's sex (OR: 1.09, 95% CI: 0.76-1.56) or patient's sex (OR: 0.85, 95% CI: 0.62-1.17), surgeon-patient sex concordance and discordance) and the likelihood of secondary surgery were found. However, healing by secondary intention (OR: 4.28; 95% CI: 1.94-9.45) and cancer location showed an increased re-resection rate. In conclusion, FSC surgery is a safe method unaffected by sex-specific factors, which had no impact on the re-resection rate. However, in further analysis, the likelihood of a re-resection was influenced by other factors such as healing by secondary intention and cancer location. This knowledge might be useful to provide an algorithm for personalized treatment strategies in the future.
Identifiants
pubmed: 37623444
pii: jpm13081193
doi: 10.3390/jpm13081193
pmc: PMC10456042
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
Fam Pract. 2014 Dec;31(6):706-13
pubmed: 25214508
Adv Exp Med Biol. 2020;1268:123-139
pubmed: 32918216
BMJ. 2017 Oct 10;359:j4366
pubmed: 29018008
JAMA Intern Med. 2017 Feb 1;177(2):206-213
pubmed: 27992617
J Am Acad Dermatol. 2019 Feb;80(2):303-317
pubmed: 29782900
Cancer Epidemiol Biomarkers Prev. 2017 Dec;26(12):1804-1811
pubmed: 29021217
Facial Plast Surg Clin North Am. 2012 Nov;20(4):419-22
pubmed: 23084294
JAMA. 1999 Aug 11;282(6):583-9
pubmed: 10450723
Women Health. 2008;48(2):123-44
pubmed: 19042213
JAMA Surg. 2022 Feb 1;157(2):146-156
pubmed: 34878511
J Am Acad Dermatol. 2018 Mar;78(3):560-578
pubmed: 29331386
Head Neck. 2003 Apr;25(4):289-96
pubmed: 12658733
Cancers (Basel). 2022 Oct 25;14(21):
pubmed: 36358649
Australas J Dermatol. 2016 Aug;57(3):e100-4
pubmed: 25833383
J Geriatr Oncol. 2016 Jan;7(1):10-4
pubmed: 26769145
Semin Oncol Nurs. 2013 Aug;29(3):160-9
pubmed: 23958214
Br J Oral Maxillofac Surg. 2021 Dec;59(10):1264-1269
pubmed: 34275678
J Natl Compr Canc Netw. 2010 Aug;8(8):888-96
pubmed: 20870635
J Am Acad Dermatol. 2018 Mar;78(3):540-559
pubmed: 29331385